Υπηρεσίες Εταιρικής Υποστήριξης

Major aims are to evaluate the (1) cost, (2) cost-effectiveness and effects on disparities, and (3) political and legal feasibility of implementing specific evidence-based policy strategies to improve diet and reduce cardiovascular disease (CVD) in the US. A key strength of this project is the involvement of experienced national and international investigators and collaborators who together provide a strong, cohesive multi-disciplinary team. This work will also leverage our existing Policy Advisory Group (PAG), formed from our existing NIH-funded work, that includes key experts with knowledge and expertise on the implementation of these national policies. This innovative investigation will provide high impact findings on the cost, cost-effectiveness, influence on disparities, and political and legal feasibility of promising dietary policies to reduce cardiometabolic disease in the US. These evaluations will provide essential insights for evidence-based preventive efforts, identify important gaps for future studies, and advance the methodology of such assessments. Identifying and implementing effective, cost-effective, and feasible interventions that could improve Americans’ diets will be crucial to allow sensible use of resources, reduce cardiometabolic burdens, and provide data on benefits beyond health, including economic gains from increased productivity, delayed events, and reduced health care utilization. The findings will be critical to inform the planning, implementation and evaluation of evidence-based dietary strategies to achieve optimal cardiometabolic health and reduce inequities for all Americans.

Major aims are to assess potential utility of household budget survey datasets for assessing individual-level dietary intakes. The methodology will be used by the World Bank to more accurately estimate poverty lines in underdeveloped and developing countries that rely on household budget surveys to estimate dietary and energy intake.

Major aims are to assess and quantify the relationship between n-6 polyunsaturated fatty acid biomarkers (linoleic acid and arachidonic acid) and (1) incident type 2 diabetes mellitus and (2) cardiovascular disease in 30 cohorts globally within the FORCE Consortium.

Major aims are to evaluate the comparative-effectiveness of evidence-based population interventions to improve diet globally, and their projected impact on CVD, other chronic diseases, mortality, and DALYs in the US.

Major aims are to (1) update and expand data on global dietary intakes in adults, including of new nutritional risk factors, from new primary data sources, and in subgroups by rural/urban and income status; (2) assess global dietary intakes in youth (from infancy to adolescence) and pregnant/nursing mothers, including of foods/nutrients implicated in deficiency conditions and relevant for diet quality; (3) evaluate and quantify the health impact of specific dietary factors throughout the lifespan, with a particular focus on maternal, pregnancy, and infant/child health outcomes relevant in Africa and Asia; and (4) characterize and compare cost-effectiveness of specific diet policy interventions to reduce the identified burdens.

Major aims are to systematically evaluate global dietary quality in women, including by age and time, in all nations around the globe; to determine using nationally representative data the price and income elasticities of dietary intakes across regions, countries, and time, and differences by age and sex; and to quantify the validity of FAO food balance sheets, including evaluation of heterogeneity.